Ras Induces Mediator Complex Exchange on C/EBPβ

Molecular Cell

Volumn 13, Issue 2, 2004, Pages 241-250

  Mo, Xianming ^a   Kowenz Leutz, Elisabeth ^a   Xu, Hong ^a   Leutz, Achim ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CYCLIN DEPENDENT KINASE 8; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PROTEIN SUBUNIT; RAS PROTEIN; RNA POLYMERASE II;

ARTICLE; CONFORMATIONAL TRANSITION; MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION INITIATION;

EID: 0842310355     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00521-5     Document Type: Article

References (54)

1. Asturias F.J., Jiang Y.W., Myers L.C., Gustafsson C.M., Kornberg R.D. Conserved structures of mediator and RNA polymerase II holoenzyme. Science. 283:1999;985-987.
2. Balciunas D., Galman C., Ronne H., Bjorklund S. The Med1 subunit of the yeast mediator complex is involved in both transcriptional activation and repression. Proc. Natl. Acad. Sci. USA. 96:1999;376-381.
3. Bhoite L.T., Yu Y., Stillman D.J. The Swi5 activator recruits the Mediator complex to the HO promoter without RNA polymerase II. Genes Dev. 15:2001;2457-2469.
4. Boube M., Joulia L., Cribbs D.L., Bourbon H.M. Evidence for a mediator of RNA polymerase II transcriptional regulation conserved from yeast to man. Cell. 110:2002;143-151.
5. Boyer T.G., Martin M.E., Lees E., Ricciardi R.P., Berk A.J. Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein. Nature. 399:1999;276-279.
6. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:2002;550-553.
7. Dotson M.R., Yuan C.X., Roeder R.G., Myers L.C., Gustafsson C.M., Jiang Y.W., Li Y., Kornberg R.D., Asturias F.J. Structural organization of yeast and mammalian mediator complexes. Proc. Natl. Acad. Sci. USA. 97:2000;14307-14310.
8. Eaton E.M., Sealy L. Modification of CCAAT/Enhancer binding protein beta by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3. J. Biol. Chem. 278:2003;33416-33421.
9. Emerson B.M. Specificity of gene regulation. Cell. 109:2002;267-270.
10. Fondell J.D., Ge H., Roeder R.G. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc. Natl. Acad. Sci. USA. 93:1996;8329-8333.
11. Gu W., Malik S., Ito M., Yuan C.X., Fondell J.D., Zhang X., Martinez E., Qin J., Roeder R.G. A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation. Mol. Cell. 3:1999;97-108.
12. Han S.J., Lee J.S., Kang J.S., Kim Y.J. Med9/Cse2 and Gal11 modules are required for transcriptional repression of distinct group of genes. J. Biol. Chem. 276:2001;37020-37026.
13. Holstege F.C., Jennings E.G., Wyrick J.J., Lee T.I., Hengartner C.J., Green M.R., Golub T.R., Lander E.S., Young R.A. Dissecting the regulatory circuitry of a eukaryotic genome. Cell. 95:1998;717-728.
14. Ito M., Roeder R.G. The TRAP/SMCC/Mediator complex and thyroid hormone receptor function. Trends Endocrinol. Metab. 12:2001;127-134.
15. Ito M., Okano H.J., Darnell R.B., Roeder R.G. The TRAP100 component of the TRAP/Mediator complex is essential in broad transcriptional events and development. EMBO J. 21:2002;3464-3475.
16. Jeong C.J., Yang S.H., Xie Y., Zhang L., Johnston S.A., Kodadek T. Evidence that Gal11 protein is a target of the Gal4 activation domain in the mediator. Biochemistry. 40:2001;9421-9427.
17. Kang J.S., Kim S.H., Hwang M.S., Han S.J., Lee Y.C., Kim Y.J. The structural and functional organization of the yeast mediator complex. J. Biol. Chem. 276:2001;42003-42010.
18. Kim J., Cantwell C.A., Johnson P.F., Pfarr C.M., Williams S.C. Transcriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylation. J. Biol. Chem. 277:2002;38037-38044.
19. Kingston R.E. A shared but complex bridge. Nature. 399:1999;199-200.
20. Kowenz-Leutz E., Leutz A. A C/EBP β isoform recruits the SWI/SNF complex to activate myeloid genes. Mol. Cell. 4:1999;735-743.
21. Kowenz-Leutz E., Twamley G., Ansieau S., Leutz A. Novel mechanism of C/EBP beta (NF-M) transcriptional control. activation through derepression Genes Dev. 8:1994;2781-2791.
22. Lamb J., Ramaswamy S., Ford H.L., Contreras B., Martinez R.V., Kittrell F.S., Zahnow C.A., Patterson N., Golub T.R., Ewen M.E. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell. 114:2003;323-334.
23. Lemon B., Tjian R. Orchestrated response. a symphony of transcription factors for gene control Genes Dev. 14:2000;2551-2569.
24. Liao S.M., Zhang J., Jeffery D.A., Koleske A.J., Thompson C.M., Chao D.M., Viljoen M., van Vuuren H.J., Young R.A. A kinase-cyclin pair in the RNA polymerase II holoenzyme. Nature. 374:1995;193-196.
25. Malik S., Roeder R.G. Transcriptional regulation through Mediator-like coactivators in yeast and metazoan cells. Trends Biochem. Sci. 25:2000;277-283.
26. Mo X., Dynan W.S. Subnuclear localization of Ku protein. functional association with RNA polymerase II elongation sites Mol. Cell. Biol. 22:2002;8088-8099.
27. Myers L.C., Kornberg R.D. Mediator of transcriptional regulation. Annu. Rev. Biochem. 69:2000;729-749.
28. Myers L.C., Gustafsson C.M., Hayashibara K.C., Brown P.O., Kornberg R.D. Mediator protein mutations that selectively abolish activated transcription. Proc. Natl. Acad. Sci. USA. 96:1999;67-72.
29. Naar A.M., Beaurang P.A., Zhou S., Abraham S., Solomon W., Tjian R. Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature. 398:1999;828-832.
30. Naar A.M., Taatjes D.J., Zhai W., Nogales E., Tjian R. Human CRSP interacts with RNA polymerase II CTD and adopts a specific CTD-bound conformation. Genes Dev. 16:2002;1339-1344.
31. Nakajima T., Kinoshita S., Sasagawa T., Sasaki K., Naruto M., Kishimoto T., Akira S. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc. Natl. Acad. Sci. USA. 90:1993;2207-2211.
32. Ness S.A., Kowenz-Leutz E., Casini T., Graf T., Leutz A. Myb and NF-M. combinatorial activators of myeloid genes in heterologous cell types Genes Dev. 7:1993;749-759.
33. Peterson C.L., Workman J.L. Promoter targeting and chromatin remodeling by the SWI/SNF complex. Curr. Opin. Genet. Dev. 10:2000;187-192.
34. Rachez C., Lemon B.D., Suldan Z., Bromleigh V., Gamble M., Naar A.M., Erdjument-Bromage H., Tempst P., Freedman L.P. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature. 398:1999;824-828.
35. Rask K., Thorn M., Ponten F., Kraaz W., Sundfeldt K., Hedin L., Enerback S. Increased expression of the transcription factors CCAAT-enhancer binding protein-beta (C/EBBeta) and C/EBzeta (CHOP) correlate with invasiveness of human colorectal cancer. Int. J. Cancer. 86:2000;337-343.
36. Samuelsen C.O., Baraznenok V., Khorosjutina O., Spahr H., Kieselbach T., Holmberg S., Gustafsson C.M. TRAP230/ARC240 and TRAP240/ARC250 Mediator subunits are functionally conserved through evolution. Proc. Natl. Acad. Sci. USA. 100:2003;6422-6427.
37. Screpanti I., Romani L., Musiani P., Modesti A., Fattori E., Lazzaro D., Sellitto C., Scarpa S., Bellavia D., Lattanzio G.et al. Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO J. 14:1995;1932-1941.
38. Singh N., Han M. sur-2, a novel gene, functions late in the let-60 ras-mediated signaling pathway during Caenorhabditis elegans vulval induction. Genes Dev. 9:1995;2251-2265.
39. Spergel J.M., Hsu W., Akira S., Thimmappaya B., Kishimoto T., Chen-Kiang S. NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A. J. Virol. 66:1992;1021-1030.
40. Stacey D.W., Feig L.A., Gibbs J.B. Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras. Mol. Cell. Biol. 11:1991;4053-4064.
41. Sterneck E., Muller C., Katz S., Leutz A. Autocrine growth induced by kinase type oncogenes in myeloid cells requires AP-1 and NF-M, a myeloid specific, C/EBP-like factor. EMBO J. 11:1992;115-126.
42. Sterneck E., Tessarollo L., Johnson P.F. An essential role for C/EBPbeta in female reproduction. Genes Dev. 11:1997;2153-2162.
43. Stevens J.L., Cantin G.T., Wang G., Shevchenko A., Berk A.J. Transcription control by E1A and MAP kinase pathway via Sur2 mediator subunit. Science. 296:2002;755-758.
44. Sun X., Zhang Y., Cho H., Rickert P., Lees E., Lane W., Reinberg D. NAT, a human complex containing Srb polypeptides that functions as a negative regulator of activated transcription. Mol. Cell. 2:1998;213-222.
45. Sundfeldt K., Ivarsson K., Carlsson M., Enerback S., Janson P.O., Brannstrom M., Hedin L. The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo. specific increase in C/EBPbeta during epithelial tumour progression Br. J. Cancer. 79:1999;1240-1248.
46. Swanson M.J., Qiu H., Sumibcay L., Krueger A., Kim S.J., Natarajan K., Yoon S., Hinnebusch A.G. A multiplicity of coactivators is required by Gcn4p at individual promoters in vivo. Mol. Cell. Biol. 23:2003;2800-2820.
47. Taatjes D.J., Naar A.M., Andel F. III, Nogales E., Tjian R. Structure, function, and activator-induced conformations of the CRSP coactivator. Science. 295:2002;1058-1062.
48. Tanaka T., Akira S., Yoshida K., Umemoto M., Yoneda Y., Shirafuji N., Fujiwara H., Suematsu S., Yoshida N., Kishimoto T. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell. 80:1995;353-361.
49. Tanaka T., Yoshida N., Kishimoto T., Akira S. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J. 16:1997;7432-7443.
50. Williams S.C., Baer M., Dillner A.J., Johnson P.F. CRP2 (C/EBP beta) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity. EMBO J. 14:1995;3170-3183.
51. Woychik N.A., Hampsey M. The RNA polymerase II machinery. structure illuminates function Cell. 108:2002;453-463.
52. Yeh W.C., Cao Z., Classon M., McKnight S.L. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 9:1995;168-181.
53. Zahnow C.A., Younes P., Laucirica R., Rosen J.M. Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer. J. Natl. Cancer Inst. 89:1997;1887-1891.
54. Zhu S., Yoon K., Sterneck E., Johnson P.F., Smart R.C. CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. Proc. Natl. Acad. Sci. USA. 99:2002;207-212.